Zhejiang Orient Gene Biotech Initial Public Offering

On Feb 5, Zhejiang Orient Gene Biotech (ZOG), Healgen Scientific's parent company, made its initial public offering within Shanghai Stock Exchange. We congratulate ZOG for this landmark event.

Zhejiang Orient Gene Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic products. Its main product includes point-of-care testing instant diagnostic reagent. The company also focuses on the development of molecular diagnostics, biological materials, diagnostic instruments and liquid biochips business. The company was founded on December 1, 2005 and is headquartered in Huzhou, China.


For more information on ZOG please visit their website at: https://www.orientgene.com/